Elective Resection of Rectal Cancer Primary Tumor in Patients with Stage IV Disease - Own Experiences

• Authors: Mirosław Halczak , Piotr Wojtasik , Tariq Al-Amawi , Józef Kładny
• Languages of publication: EN

Abstracts

EN

Optimal management of asymptomatic generalized rectal cancer is still the matter of debate.The aim of the study was to review stage IV rectal cancer patients who were treated in our clinic since 2000 till 2008 in order to evaluate the effectiveness of surgery.Material and methods. Fifty-two generalized rectal cancer patients treated with elective resection of primary tumor were identified. Patients' age, sex, duration of hospital stay, modality of surgery, complications, postoperative mortality rate and survival rate were assessed.Results. Median survival was 16.3 months. Postoperative complications occurred in 29% patients. Postoperative mortality rate was 1.9%.Conclusions. In properly selected group of patients elective resection of primary tumor may cause low mortality rate and acceptable morbidity rate. This surgical modality allows to avoid potential complications of tumor local growth.

Keywords

EN

surgery; stage IV; rectal cancer

• Publisher: De Gruyter Open
• Journal: Polish Journal of Surgery
• Year: 2011
• Volume: 83
• Issue: 7
• Pages: 372-376

Dates

published

1 - 7 - 2011

online

21 - 9 - 2011

Contributors

author

Mirosław Halczak

• Department of Surgical Oncology, Pomeranian Medical University in Szczecin

author

Piotr Wojtasik

• Department of Surgical Oncology, Pomeranian Medical University in Szczecin

author

Tariq Al-Amawi

• Department of Surgical Oncology, Pomeranian Medical University in Szczecin

author

Józef Kładny

• Department of Surgical Oncology, Pomeranian Medical University in Szczecin

References

• Boyle P, Leon ME: Epidemiology of colorectal cancer. Br Med Bull 2002; 64: 125.
• ---
• Cook AD, Single R, McCahill LE: Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005; 12: 637-45.
• Costi R, Mazzeo A, Di Mauro D et al.: Palliative resection of colorectal cancer: does it prolong survival? Ann Surg Oncol 2007; 14: 2567-76.[Crossref][PubMed]
• Liu SK, Church JM, Lavery IC et al.: Operation in patients with incurable colon cancer - is it worth-while? Dis Colon Rectum 1997; 40: 11-14.[Crossref]
• Rosen SA, Buell JF, Yoshida A et al.: Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000; 135: 530134.
• Kuo LJ, Leu SY, Liu MC et al.: How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003; 46: 1646-52.[Crossref][PubMed]
• Cummins ER, Vick KD, Poole GV: Incurable colorectal carcinoma: the role of surgical palliation. Am Surg 2004; 70: 433-37.[PubMed]
• Sarela A, O'Riordain DS: Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 2001; 88(2): 163-64.
• Sarela AI, Guthrie JA, Seymour MT et al: Nonoperative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 2001; 88(10): 1352-56.
• Benoist S, Pautrat K, Mitry E et al.: Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005; 92(9): 1155-60.
• Muratore A, Zorzi D, Bouzari H et al.: Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or upfront systemic chemotherapy? Ann Surg Oncol 2007; 14(2): 766-70.[Crossref]
• Van der Burg ME, Vergote I: The role of interval debulking surgery in ovarian cancer. Curr Oncol Rep 2003; 5: 473-81.
• Flanigan RC, Salmon SE, Blumenstein BA et al.: Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001; 345: 1655-59.
• Kaufman MS, Radhakrishnan N, Roy R et al.: Influence of palliative surgical resection on overall survival in patients with advanced colorectal cancer: a retrospective single institutional study. Colorectal Dis 2008; 10: 498-502.[Crossref][PubMed][WoS]
• Law WL, Chu KW, Ho JW et al.: Self-expanding metallic stent in the treatment of colonic obstruction caused by advanced malignancies. Dis Colon Rectum 2000; 43: 1522-27.[Crossref][PubMed]
• Khot UP, Lang AW, Murali K et al.: Systematic review of the efficacy and safety of colorectal stents. Br J Surg 2002; 89: 1096-02.
• Law WL, Chu KW: Outcomes of resection of stage IV rectal cancer with mesorectal excision. J Surg Oncol 2006; 93: 523-28.[PubMed][Crossref]
• Smothers L, Hynan L, Fleming J et al: Emergency surgery for colon carcinoma. Dis Colon Rectum 2003; 46(1): 24-30.[Crossref]
• Stillwell AP, Buettner PG, Ho YH: Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 2010; 34: 797-807.[Crossref][PubMed]
• Tebbutt NC, Norman AR, Cunningham D et al.: Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003; 52: 568-73.[PubMed][Crossref]
• Nash GM, Saltz LB, Kemeny NE et al.: Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002; 9: 954-60.[PubMed][Crossref]
• Evans MD, Escofet X, Karandikar SS et al.: Outcomes of resection and non-resection strategies in management of patients with advanced coclorectal cancer. World J Surg Oncol 2009; 7: 28.[PubMed][Crossref]

Identifiers

DOI

10.2478/v10035-011-0059-8